Duygu Has Şimşek

Can Complementary ⁶⁸Ga-DOTATATE and ¹⁸F-FDG PET/CT Establish the Missing Link Between Histopathology and Therapeutic Approach in Gastroenteropancreatic Neuroendocrine Tumors?

Duygu Has Şimşek, Serkan Kuyumcu, Cüneyt Türkmen et al. · Journal of Nuclear Medicine · 2014 · 95 citations · Full text

Safety of Fibroblast Activation Protein–Targeted Radionuclide Therapy by a Low-Dose Dosimetric Approach Using 177Lu-FAPI04

Serkan Kuyumcu, Bilal Kovan, Fikret Büyükkaya et al. · Clinical Nuclear Medicine · 2021 · 87 citations

The utility of FDG-PET/CT as an effective tool for detecting recurrent colorectal cancer regardless of serum CEA levels

Serkan Kuyumcu, Zeynep Gözde Özkan, Cüneyt Türkmen et al. · Annals of Nuclear Medicine · 2012 · 59 citations

Positron Emission Tomography, Oncologic Imaging, Medical Imaging +10

Diagnostic value of PET/CT is similar to that of conventional MRI and even better for detecting small peritoneal implants in patients with recurrent ovarian cancer

Cüneyt Türkmen, Cem İyibozkurt, Sevda Özel et al. · Nuclear Medicine Communications · 2012 · 55 citations

Does bone scintigraphy still have a role in the era of 68 Ga-PSMA PET/CT in prostate cancer?

Duygu Has Şimşek, Caner Civan, Müge Nur Engin et al. · Annals of Nuclear Medicine · 2020 · 31 citations

Positron Emission Tomography, Urology, Does Bone Scintigraphy +11